Moreover, the loss of HOXA5 could promote PCa malignancy, EMT phenotype and drive cancer stemness through a previously-unreported TRAF7/HOXA5/SPRY2–MEK/ERK signaling axis. The gene discussed is MAP2K7; the disease is cancer.